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Abstract: Background: A growing body of epidemiological and clinical evidence has implicated
air pollution as an emerging risk factor for cardiometabolic disease. Whilst individuals spend up
to two-thirds of daily time in their domestic residential environment, very few studies have been
designed to objectively measure the sub-clinical markers of cardiometabolic risk with exposure to
domestic indoor air pollutants. This cross-sectional study aims to investigate associations between
the components of domestic indoor air quality and selected sub-clinical cardiometabolic risk factors
in a cohort of healthy adults living in Perth, Western Australia. Methods: One hundred and eleven
non-smoking adults (65% female) living in non-smoking households who were aged between 35–69
years were recruited for the project. Study subjects were invited to participate in all sections of the
study, which included: Domestic indoor air monitoring along with the concurrent 24 h ambulatory
monitoring of peripheral and central blood pressure and measures of central hemodynamic indices,
standardized questionnaires on aspects relating to current health status and the domestic environment,
a 24 h time-activity diary during the monitoring period, and clinic-based health assessment involving
collection of blood and urine biomarkers for lipid and glucose profiles, as well as measures of renal
function and an analysis of central pulse wave and pulse wave velocity. Results: This study provides
a standardized approach to the study of sub-clinical cardiometabolic health effects that are related to
the exposure to indoor air pollution. Conclusion: The findings of this study may provide direction
for future research that will further contribute to our understanding of the relationship that exists
between indoor air pollution and sub-clinical markers of cardiometabolic risk.
Keywords: Indoor air pollution; cardiovascular; metabolic; blood pressure; risk factors;
diabetes mellitus
1. Introduction
In recent years, exposure to environmental pollutants has been hypothesized as having an
important role in the development and severity of cardiometabolic disease (CMD) [1–3], with studies
suggesting that exposure to ambient air pollution might adversely affect a range of sub-clinical
cardiometabolic endpoints including blood pressure (BP), glucose and lipid metabolism, and vascular
function [4–10].
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Ambient air pollution is composed of complex mixtures of contaminants including particulate
matter (PM), gases (e.g., nitrogen oxides, carbon monoxide, and sulphur dioxide) and volatile organic
compounds (e.g., formaldehyde) [11,12]. PM itself is a combination of a multitude of solid particles from
many sources that differ in size and chemical composition. It is also the portion of air pollution most
consistently held responsible for the majority of pollution-related health effects [13]. PM is commonly
classified by its aerodynamic diameter: ≤ 10 µm (“thoracic” particles or PM10), 10–2.5 µm (“coarse”
particles or PM10–2.5), ≤2.5 µm (“fine” particles or PM2.5) and <0.1 µm (“ultrafine” particles—UFP).
Health problems related to exposure to PM have been reported to be directly linked to their size [14].
Previous studies have reported BP increases high enough to trigger cardiovascular events such as
strokes and heart failure following ambient air pollution exposures [15–19]; however, findings have
been inconsistent [20,21]. Though there have been few, other studies have investigated hemodynamic
parameters related to BP that quantify cardiovascular function [19]. Of these limited studies, significant
positive associations have been reported between ambient [6,7] and household air pollution [22]
exposure, with impaired hemodynamic measures including mean arterial pressure (a surrogate
measure for tissue and organ perfusion pressure), augmentation index (a correlate of arterial stiffness
and wave reflection), pulse pressure and pulse wave velocity (measures of arterial stiffness).
Additionally, several recent studies in developing countries have evaluated the relationship
between ambient and household air pollution with dyslipidemia (abnormal blood lipid
levels) [8,9,23–27]. Dyslipidemia is closely linked to the development and progression of atherosclerosis,
and positive associations have been reported between elevated levels of air pollution with total
cholesterol [8,9,24], triglycerides [8,9,23,26], and low density lipoproteins [8,9,26]. However, findings
have been inconsistent across all studies [25,27].
Similar mixed results have been observed where the effects of air pollution exposure have been
examined with glucose homeostatic measures such as fasting glucose and glycosated hemoglobin
(Hb1Ac) levels [23,24,26,28,29]. HbA1c is a well acknowledged biomarker that reflects average plasma
glucose levels over the previous six-to-eight weeks, and an elevated HbA1c level denotes an increased
risk of developing diabetes [28]. In a cross-sectional study by Liu et al. [28], positive associations
were reported between higher levels of ambient air pollution and both fasting glucose and HbA1c.
In contrast, Chuang and colleagues [23] reported an association between higher levels of ambient PM
air pollution and HbA1c but not with fasting glucose. Additionally, in a study of Honduran women,
positive associations were observed between HbA1c and elevated concentrations of household air
pollution from biomass cookstoves [29].
Whilst most published studies of human exposure have related to ambient air pollution, it is well
recognized that exposure to air pollution occurs in both outdoor and indoor environments [12], with
indoor air quality issues becoming increasingly recognized as important risk factor for human health
in low-, middle-, and high-income countries alike [30].
Indoor air pollution is a heterogeneous combination of particles and gases with concentrations
affected by infiltrating outdoor particles, emissions from indoor sources, and particles formed indoors
through reactions and secondary processes [31,32]. In high-income countries such as Australia, gas and
electric cooking appliances along with heating and cooling appliances, furniture, dust re-suspension
and indoor combustion of solid fuels (e.g., wood and coal) are significant contributors to indoor air
pollution [31,33,34]. In contrast, major sources of indoor air pollution in low- and middle-income
countries traditionally involve cooking and heating using solid fuels such as crop residues, dung, or
wood in poorly ventilated homes [22,25,29,35,36].
It is well reported that in high-income countries, approximately two-thirds of indoor time is spent
in the home [37–39]. Despite this, there have been few published studies that have quantitatively
examined the relationship between indoor air quality (IAQ) and associated cardiometabolic health
effects in high-income countries [19,40], although several studies have investigated this relationship in
low- and middle-income countries [22,25,29,41,42].
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The primary aim of this research was to investigate associations between sub-clinical
cardiometabolic risk markers with indoor air pollutants in healthy middle-aged adults residing
in Perth, Western Australia. Our research hypothesis assumed that acute exposure to a number of
indoor air pollutants would be independently and adversely associated with a range of sub-clinical
cardiometabolic risk factors.
2. Materials and Methods
2.1. Study Design
A cross-sectional study conducted in a cohort of healthy middle-aged adults living in the
metropolitan area of Perth, Western Australia.
2.2. Study Location and Population
Perth is the capital of Western Australia. It is a typical Australian capital city with a population of
approximately 2.1 million people densely situated around the capital [43], although ambient air quality
is considered to be of a high standard compared with other Australian and international cities [44].
For this study, we recruited 181 adults, of which 70 were subsequently excluded due to ineligibility
with study criteria. The study population selection is depicted at Figure 1. Participants were
initially invited to join the study through local radio advertising and a group email to all staff
of the hosting University. Further participants were recruited through word-of-mouth. Prior to
enrolment, participants were screened for eligibility by a seven-question telephone interview or
electronic questionnaire.
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(n = 181) 
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1. No response post expression of 
interest (n = 9) 
2. Taking non-permitted 
medications (n = 11)  
3. Outside of age range (n = 7) 
4. Withdrew (n = 43) 
Eligible Participants 
(n = 111, 65% female) 
Study Criteria Screening 
Inclusion criteria:  
• Non-smoker in non-smoking household; 
• Aged 35–69 years; 
Exclusion criteria: 
• Medically diagnosed CVD, history of 
cardiac events or diabetes; 
• Use of anti-hypertensive or lipid 
modifying medications; 
• Lack of written consent. 
Figure 1. Study opulation recruitment process.
Adults meeting the following criteria were included in the study:
Inclusion criteria:
• Non-smokers living in a non-smoking household.
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• Aged between 35 and 69 years.
Exclusion criteria:
• A history of cardiovascular events or medical diagnosis of cardiovascular disease (CVD).
• Medically diagnosed diabetes.
• Use of anti-hypertensive or lipid modifying medications.
• Lack of written consent.
2.3. Data Collection
For each participant, data were collected once, although collection involved two stages. Stages 1
and 2 were arbitrarily assigned a number order; however, participants were offered the opportunity to
select the stage that was undertaken first. All data collection was carried out by the same investigator
following standard protocols. Due to the logistical challenges required to coordinate equipment,
investigator availability, and participant preferences, a 14 day limit was set as the maximum time
period to complete both stages. Stages 1 and 2 are described in further detail below.
• Stage 1: In-home equipment installation—the measurement of domestic indoor air quality in
participants home and ambulatory blood pressure (ABP)/hemodynamic indices over a concurrent
24 h period. Participants were also requested to complete questionnaires related to health
and domestic environment and to complete a 24 h time/activity diary during the 24 h IAQ/BP
monitoring period.
• Stage 2: Clinic-based health assessment—data relating to baseline health characteristics,
cardiometabolic biomarkers and measures, and pulse wave analysis were collected.
2.4. In-Home Assessment
Residential indoor and outdoor pollutant concentrations and ambulatory BP and hemodynamic
indices were measured over one concurrent 24 h period. All participants were requested to undertake
their daily tasks as usual during the monitoring period.
Indoor air pollutants were measured in the main living area and included: Total particulate matter
(TPM), PM10, PM4, PM2.5, PM1, UFP, formaldehyde (HCHO), total volatile organic compounds (TVOCs),
nitrogen dioxide (NO2), carbon monoxide (CO) and carbon dioxide (CO2). Ancillary measurements
included temperature and relative humidity (RH). Due to limitations with equipment availability,
outdoor measurements were conducted only for PM (TPM, PM10, PM4, PM2.5 and PM1). The in-home
assessment was undertaken at a time convenient to participants prior to 4 pm. Due to operational
limitations of the instrumentation, UFP measurements were undertaken for 6 hs only, between 4 pm
and 10 pm.
Outdoor air monitoring equipment was placed in the closest powered location to the house, under
shade for protection from rain and sunlight [32], and away from any combustion sources such as
barbeques and driveways [45]. Indoor and outdoor residential sampling was conducted at a height of
1.5 m, which is the approximate breathing zone of a standing adult [45]. Air sampling was undertaken
on weekdays and weekends, as recent research has established that mass concentrations of fine (PM2.5)
and coarse particles (PM10-2.5) do not differ in relation to days of the week [46].
2.4.1. Measurement of Air Quality and Instrumentation
Air quality was determined using instruments that measure particle mass concentrations (µg/m3;
DustTrak DRX 8533. TSI Inc., Shoreview, MN, USA), UFP number concentration (particles/cm3; P-Trak
model 8525. TSI Inc., Shoreview, MN, USA), total volatile organic compounds (TVOC; ppb), carbon
dioxide (CO2; ppm), carbon monoxide (CO; ppm), nitrogen dioxide (NO2; ppm), temperature (◦C)
and relative humidity (%RH) (Advanced Sense Pro. Gray Wolf Sensing Solutions, Shelton, CT, USA),
Int. J. Environ. Res. Public Health 2019, 16, 3548 5 of 14
and formaldehyde (HCHO; µg/m3) (Formaldehyde Multimode Monitor FM-801. Gray Wolf Sensing
Solutions, Shelton, CT, USA).
The DustTrak DRX 8533 is a light-scattering laser photometer that simultaneously measures
real-time aerosol mass readings for five particle size fractions (TPM, PM10, PM4, PM2.5, PM1) [47].
Two DustTrak 8533 instruments were used at each dwelling to simultaneously measure indoor and
outdoor air quality for the 24 h monitoring period. Both instruments were pre-set with residential
location details before commencing monitoring. The measuring range of the instrument was
1–150 × 103 µg/m3 with an accuracy of ±0.1%. Flow rate was factory set at 3.0 L/min. DustTrak
was programmed to log data at 5 min intervals for the full 24 hs.
Zero calibration for both instruments was conducted on-site prior to the commencement of data
logging to minimize the effect of zero drift. Instruments were factory calibrated for flow rate prior to
the commencement of the project, and flow rates were intermittently checked during the course of the
project by a calibrated rotameter (TSI LPM-air).
A portable P-Trak 8525 was used to detect and count UFP < 1 µm in real-time. P-Trak displayed
the measured particle concentration in units of particles per cubic centimeter (particles/cm3), and the
instrument’s measuring range was from 0 to 500,000 particles/cm3. The flow rate for the sampling was
approximately 100 cm3/min [48]. The alcohol wick used by P-Trak had a limit of operation of 8 hs at
21 ◦C before requiring re-saturation [49], and, as such, the instrument was programmed to only log
data for a 6 h period. Data were logged at 5 min intervals.
Data from both the DustTrak 8533 and P-Trak 8525 were downloaded using TrakPro data
analysis software.
Gaseous pollutants were measured using the Gray Wolf AdvancedSense Pro fitted with a sensor
probe measuring TVOCs, CO2, CO, NO2, RH, and temperature. A separate, supplementary monitor
was attached to the AdvancedSense Pro measuring HCHO (Multimode monitor FM-801).
Both instruments were pre-set with residential location details before commencing monitoring
and programmed to log data at 30 min intervals.
2.4.2. Measurement of Ambulatory BP and Hemodynamic Indices
An ambulatory BP monitor (ABPM) (Oscar 2, Sun Tech Medical, Inc., Morrisville, NC, USA) was
fitted to the left arm of the participant, having been pre-programmed to obtain readings at 30 min
intervals for the full 24 hs. The device was programmed to automatically attempt an additional
measurement 4 min later if the previous was unsuccessful due to participant movement or positioning.
Measurements collected from ABPM included: 24 h central and peripheral systolic BP (SBP); 24 h
central and peripheral diastolic BP (DBP); day-time central and peripheral SBP; night-time central and
peripheral DBP (all BP measurements were in mmHg); 24 h, day-time and night-time heart rate (beats
per minute; bpm); central and peripheral systolic and diastolic nocturnal dip (%), central augmentation
index (AIx; %) along with AIx adjusted for heart rate (AI75; %); and central and peripheral augmented
pressure, pulse pressure and mean arterial pressure (all measured in mmHg).
Awake and asleep periods were determined from time-activity diaries maintained by participants
for the 24 h monitoring period, and used the same method as several other studies [50–52].
Following standard protocol described in Parati et al. [52] and O’Brien et al. [51], measurements
were deemed valid and included in the final analyses if 70% of the 24 h measurements were obtained,
and 20 valid awake and 7 valid asleep measurements were achieved. When < 70% of 24 h readings
were achieved, further investigation was undertaken of edited day-time and night-time readings.
Day-time or night-time measurements that did not pass validity criteria for the time period (day-time:
20 valid readings; night-time: 7 valid readings) were discarded and excluded from the final analyses
by a process described in similar studies [51,53]. All valid day-time and night-time readings were
averaged to provide a single day-time and night-time ABP value per study participant [53].
At the end of the 24 h ± 2 hs sampling period, equipment and completed questionnaires were
collected from participants’ homes.
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2.4.3. Questionnaires and Time-Activity Diary
Each participant was provided with two questionnaires and a time-activity diary to be completed
during the 24 h monitoring.
Participant demographics including address, age, gender and ethnicity (country of birth, parents
country of birth), along with information on health and lifestyle behaviors, were gathered by an
adapted version of the American Thoracic Society standardized IAQ and health questionnaire that has
also been used in several other Australian studies [40,54–56]. In the health questionnaire, participants
self-reported on factors including smoking status (yes, no), alcohol intake (more or less than two
alcoholic drinks per day), medications taken, and comorbidities including conditions such as asthma,
chronic obstructive pulmonary disease, kidney disease and thyroid conditions. From the demographic
data collected, socioeconomic status was assigned using census-track data collected by the Australian
Bureau of Statistics [57] and by using post codes to rank participants homes according to relative
socio-economic advantage (low, medium or high).
Participants also completed a questionnaire to report on the characteristics of their domestic
environment; a questionnaire which has been used in several previous studies examining IAQ [54–56].
Survey questions asked about indoor air pollution sources such as cooking technology used (gas,
electric or both), heating (flued and unflued gas, wood, coal, oil, kerosene, electric, or reverse cycle air
conditioning) and cooling devices (fans, refrigerated air conditioning, or evaporative air conditioning),
floor and wall coverings, renovations (painting, building, renovations in previous three months; yes,
no), cleaning habits (frequency and types of products), and garage location (attached to the home by
inner door or not attached).
Additionally, participants reported their time-activity for the 24 h monitoring period, indicating
for each two hour period their presence indoors/outdoors, and their presence at home/work/other.
Other recorded activities included their sleep schedule (awake time and asleep time) or any situations
they consider important (e.g., stressful situations or unusual sleep times). Data collected using this
method is consistent with other similar studies [45,58].
2.5. Clinic Assessment
Participants attended the Curtin University Clinical Health Suites for a health assessment after
having fasted for 12 hs (other than water and regular medications) prior [59].
Participants’ height (m) and weight (kg) were measured in bare feet and wearing light clothing.
Weight was measured by a mechanical scale (SECA 762, SECA, Hamburg, Germany) and height was
measured by a stadiometer (S + M. Surgical and Medical Products, Preston, VIC, Australia). Body mass
index (BMI) was calculated by dividing body weight (kg) by the squared height (m2). Waist (cm) and
hip circumference (cm) were measured using a non-stretch, retractable tape. After following standard
protocol for identifying the level of the natural waist and hips and assuring the tape was level, the
hip circumference was recorded. Waist circumference was measured at the end of a participant’s
normal expiration. The waist-to-hip ratio was calculated by dividing the waist measurement by the
hip measurement [59].
Brachial (peripheral) blood pressure (mmHg) was measured after a 5 min rest in the sitting
position. BP recordings on both arms were made one minute apart using an automated monitor
(HEM-907, Omron Healthcare, Kyoto, Japan) [60]. The mean of three measures was considered the
brachial BP and was calculated independently for both arms.
Two finger stick blood samples were collected using an aseptic technique. These samples
were immediately analyzed for lipids (total cholesterol, high density lipoprotein [HDL], low density
lipoprotein [LDL], non-HDL, triglycerides, fasting glucose [all in mmol/L], and glycosated haemoglobin
[HbA1c; %]). A spot mid-stream urine sample was requested for the determination of albumin (mg/L),
creatinine (mmol/L) and albumin/creatinine ratio (ACR, mg/mmol). Lipid levels, HbA1c and urine
analysis was conducted using the appropriate reagent containing cassettes of the fully automated
biochemistry analysis system (Alere Afinion AS100, Waltham, MASS, USA).
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Fasting glucose was analyzed by a hand-held Accu-Chek Blood Glucose Meter (Roche Diabetes
Care, Mannheim, Germany) using blood drawn from a finger stick test.
Pulse Wave Analysis and Pulse Wave Velocity
Central BP and wave-forms were non-invasively measured with the participant in a supine
position (SphygmoCor EM3 XCEL, AtCor Medical Pty, West Ryde, Australia). Carotid–femoral pulse
wave velocity (PWV) was determined by examining the arterial waveforms of the carotid and femoral
arteries, as well as the time delay measured between the feet of the two waveforms. The distance
covered by the waves was established as 80% of the distance between the two recording sites. PWV was
calculated by SphygmoCor proprietary software as distance/time delay in m/s [61].
2.6. Data Management
Each participant was given a unique alpha-numeric identification number to secure personal data.
Data will be managed and stored according to the Australian Code for the Responsible Conduct of
Research. Electronic files will be backed up, maintained, and stored on Curtin University’s secure
Research drive, and hard copy original material including questionnaires and time-activity data will
be stored in numerical order, in a locked compactus, in a secure entry room. Access to the study data
will be restricted, and participant files will be maintained in storage for a period of seven years after
completion of the study.
2.7. Statistical Analysis
2.7.1. Sample Size and Effect
Assuming a conventional Cohen’s medium effect size of 15%, a sample size of 110 was calculated
by G power to achieve 80% power for testing both the overall significance of the multivariable linear
regression model and an individual effect attributed to the residential IAQ on cardiometabolic risk
markers at a significance level of 5%. This medium effect size is equivalent to testing an overall multiple
correlation of 0.13 and a partial correlation of 0.12, which are comparable with preliminary results
from a recent Australian study (n = 63) [40]. The final sample size obtained was further verified by
Green’s formula for general practical applications using a multivariable regression analysis [62].
2.7.2. Data Analysis
Descriptive statistics were calculated to describe the profile and characteristics of each study
participant and included demographic characteristics, some health characteristics, air pollutant
characteristics and home environment characteristics. Further descriptive statistics were computed for
all exposure and health outcomes. Values are expressed as mean (± standard deviation) for continuous
variables and number (percentage) for categorical variables. The normality of all continuous data was
assessed using histograms, boxplots, a normal Q–Q plot, and skewness and kurtosis coefficients.
Paired samples t-tests were undertaken to evaluate differences between clinic and ambulatory
blood pressure measurements. Simple associations between every outcome variable and all 24 h
average indoor pollutant concentrations were examined by using the Pearson r coefficient.
Linear mixed-effect models were then applied to investigate the associations between sub-clinical
end points of interest and indoor air pollutants. Saturated models were adjusted for potential covariates
selected a priori and on the basis of similar studies previously reported in the literature [63–65].
Single pollutant exposure models were controlled for age (continuous), gender (nominal; male, female),
BMI (continuous), waist–hip ratio (continuous) and socio-economic status (ordinal; low, medium, high).
Univariable tests were carried out to explore associations between explanatory variables and each
outcome (dependent) variable, and to identify which of the explanatory variables were individually
associated with the dependent variables. We assessed residual confounding by waist circumference,
ethnicity and alcohol consumption by adding variables individually to the base model to evaluate
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their influence on the results [17]. Effect estimates did not significantly alter with their inclusion, so
they were not included in the final model.
One participant was considered to have a contentious health and lifestyle profile (borderline
hypertension; >2 alcoholic drinks per day). However, other cardiometabolic biomarkers were in the
expected range. A sensitivity analysis was undertaken with this participant excluded; however, no
significant impact to the final results was observed following their exclusion.
The final results were reported by mean change in the outcome variable corresponding to a one
interquartile range (IQR) increase of exposure to each indoor air pollutant concentration, along with its
95% confidence interval.
A p-value ≤ 0.05 was considered statistically significant. Analyses were performed using IBM
SPSS software (Version 24.0. IBM Corp, Armonk, NY, USA.)
2.8. Ethics and Consents
This study protocol was approved by Curtin University, Human Research Ethics Committee
(HRE2016-0308). Upon enrolment, participants were provided with a study information sheet which
outlined the study procedure and the voluntary nature of their involvement. Recruits were provided
the opportunity to ask research team further questions, following which full written, informed consent
was obtained. Details of the research team are contained on the participant information sheet. Findings
from this study will be disseminated locally and at international meetings and will be published in
open access peer reviewed journals.
3. Discussion
This cross-sectional study of middle-aged, healthy individuals was designed to characterize
the associations between exposure to residential indoor air pollution and selected intermediate
cardiometabolic outcomes in a high-income setting. By using objective measurement tools for
the ascertainment of both exposure and health-related endpoints, we hoped to minimize possible
measurement errors that are likely associated with the use of estimated or inferred data.
While previous studies have focused on associations between ambient air pollution and human
health, there is increasing evidence to suggest a role for indoor air pollution [66], and indeed it has
been estimated that up to 30% of the burden of disease from exposure to air pollution can be attributed
to indoor-generated particles [67]. Indoor air pollution arises from numerous different sources along
with post-emission formation and processes, and as such, indoor air pollutants can retain complex
compositions and toxicities, with some similarities but also differences to outdoor air pollution [33].
A limitation of previous studies that have reported on relationships between indoor and outdoor
air pollution and health [68] is that the exposure of the individual was not directly observed; rather,
estimations were made by extrapolating an exposure value or exposure variation from a central fixed
monitoring site to the entire population of the study area [19,69–74]. However, this approach may
have resulted in exposure misclassification [68,75] and potentially biased estimates, as characteristics
of individual exposure may be wrongly inferred from estimated characteristics of the collective
population [68].
Similar limitations exist when considering individual level clinical cardiometabolic effects with
outcomes such as ischemic heart disease, stroke, and type 2 diabetes mellitus commonly being derived
through record linkage procedures, hospital admission/discharge registries, or by self-reporting [72,73,
76–79]. Such data are then ordinarily linked to the ecologically-derived exposure data to ascertain
the directionality of a relationship, leading to opportunities for the possibility of misclassification
based on incorrect assumptions about individual-level pollutant characteristics [68]. Acknowledging
these limitations, significant associations have been described between ambient air quality and
increased cardiometabolic risk at air pollution concentrations below recommended international
standards [12,80,81].
Similar to other studies [29,35], this current study had several limitations.
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Given the cross-sectional design, we were not able to establish temporality between exposure and
health outcomes. Though cardiometabolic measures were concurrently determined (within 14 days) to
air pollution exposure, based on our associations, it was not possible to infer causation. Additionally,
although there was up to a 14 day gap between exposure and health outcome measurements, we
considered our exposure assessment to be a plausible representation of individual habitual exposure
to air pollutants in the residential environment under normally occupied conditions. Additionally,
without significant variation in individual behavior and residential circumstances, it is unlikely that
the 14 day lag would have had appreciable influence on the results.
Though we adjusted for important and well-established confounders, residual confounding was
still a possibility due to unmeasured or incompletely measured factors. These factors include potential
effect modifiers such as genetic pre-disposition and exercise or dietary factors that can affect some of
the measured cardiometabolic markers. These are limitations that have been reported in other similar
studies [29,35].
However, there were also several notable strengths of our study. All exposure and health metrics
were directly measured without relying on surrogates or self-report, and several of these markers
are considered robust measures related to cardiometabolic risk. In our study, we examined several
measures of arterial stiffness, including pulse wave velocity (PWV) which is considered a reliable
predictor of cardiovascular events and outcomes [82]. Additionally, HbA1c is a measure that captures
chronic glucose exposure and is not influenced by short-term dietary intake. It is considered a reliable
measure of diabetic risk [83].
Finally, the findings of this research will contribute to a more thorough understanding of the
relationship between measured domestic IAQ and selected functional sub-clinical endpoints related
to cardiometabolic risk in high-income countries. Potential outcomes of this research may include
providing direction for future research to further understand the intermediate mechanistic pathways
by which air pollution might contribute to cardiometabolic risk.
The effective dissemination of findings from this research will raise awareness and potentially
provide some insight regarding the relationship between exposure and cardiometabolic response,
particularly at low and very low concentrations of airborne air pollutants, and contribute to current
understandings of whether thresholds exist for ‘safe’ exposure to indoor airborne air pollutants.
4. Conclusions
This study provides a standardized approach to the study of sub-clinical cardiometabolic health
effects that are related to exposure to indoor air pollution in a high-income setting. Given the ubiquitous
nature of indoor air pollution, objective and reliable methods to measure exposure will assist in the
quantification of its effects on health. Whilst further longitudinal work of a prospective design is
required to confirm the causal association between indoor air pollution and adverse sub-clinical
cardiometabolic outcomes, the findings from this study may provide important insights into the
mechanistic pathways by which exposure to indoor air pollution affects health outcomes and, thus,
provide the basis for future research.
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